Quantitative Assessment of Motor Neglect.


Journal

Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266

Informations de publication

Date de publication:
05 2021
Historique:
pubmed: 5 3 2021
medline: 7 1 2022
entrez: 4 3 2021
Statut: ppublish

Résumé

Background and Purpose: We used differential actigraphy as a novel, objective method to quantify motor neglect (a clinical condition whereby patients mimic hemiplegia even in the absence of sensorimotor deficits), whose diagnosis is at present highly subjective, based on the clinical observation of patients’ spontaneous motor behavior. Methods: Patients wear wristwatch-like accelerometers, which record spontaneous motor activity of their upper limbs during 24 hours. Asymmetries of motor behavior are then automatically computed offline. On the basis of normal participants’ performance, we calculated cutoff scores of left/right motor asymmetry. Results: Differential actigraphy showed contralesional motor neglect in 9 of 35 patients with unilateral strokes, consistent with clinical assessment. An additional patient with clinical signs of motor neglect obtained a borderline asymmetry score. Lesion location in a subgroup of 25 patients was highly variable, suggesting that motor neglect is a heterogenous condition. Conclusions: Differential actigraphy provides an ecological measure of spontaneous motor behavior, and can assess upper limb motricity in an objective and quantitative manner. It thus offers a convenient, cost-effective, and relatively automatized procedure for following-up motor behavior in neurological patients and to assess the effects of rehabilitation.

Identifiants

pubmed: 33657852
doi: 10.1161/STROKEAHA.120.031949
doi:

Types de publication

Clinical Trial Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1618-1627

Auteurs

Monica N Toba (MN)

Sorbonne Université, Inserm U 1127, CNRS UMR 7225, Paris Brain Institute, ICM, Hôpital de la Pitié-Salpêtrière, France (M.N.T., R.M., P.B.).
Laboratory of Functional Neurosciences (UR UPJV 4559), University of Picardy Jules Verne and University Hospital of Amiens, France (M.N.T.).

Chiara Pagliari (C)

IRCCS Fondazione Don Carlo Gnocchi, Milano, Italy (C.P., M.R., F.B.).

Marco Rabuffetti (M)

IRCCS Fondazione Don Carlo Gnocchi, Milano, Italy (C.P., M.R., F.B.).

Norbert Nighoghossian (N)

Stroke Department, Claude Bernard University Lyon 1, Laboratoire CarMeN, Inserm U 1060, Université Lyon 1, INRA U 1397, INSA Lyon, Hospices Civils de Lyon, France (N.N.).

Gilles Rode (G)

Service de médecine physique et réadaptation, Hôpital Henry-Gabrielle, Hospices Civils de Lyon, 69610 Pierre-Bénite, France (G.R.).
Inserm UMR-S 1028, CNRS UMR 5292, ImpAct, Centre de Recherche en Neurosciences de Lyon, Claude Bernard University Lyon 1, Bron, France (G.R.).
Claude Bernard University Lyon 1, 69008 Lyon, France (G.R.).

François Cotton (F)

Laboratoire CREATIS, CNRS UMR 5220, Inserm U 1206, INSA-Lyon, Claude Bernard University Lyon 1, Lyon, France (F.C.).
Service de Radiologie, Centre Hospitalier de Lyon Sud, Hospices Civils de Lyon, France (F.C.).

Lucia Spinazzola (L)

Humanitas Mater Domini Hospital, Castellanza, Italy (L.S.).

Francesca Baglio (F)

IRCCS Fondazione Don Carlo Gnocchi, Milano, Italy (C.P., M.R., F.B.).

Raffaella Migliaccio (R)

Sorbonne Université, Inserm U 1127, CNRS UMR 7225, Paris Brain Institute, ICM, Hôpital de la Pitié-Salpêtrière, France (M.N.T., R.M., P.B.).
Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Hôpital Pitié-Salpêtrière, Paris, France (R.M.).
FrontLab, ICM, Paris, France (R.M.).

Paolo Bartolomeo (P)

Sorbonne Université, Inserm U 1127, CNRS UMR 7225, Paris Brain Institute, ICM, Hôpital de la Pitié-Salpêtrière, France (M.N.T., R.M., P.B.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH